Analysts were expecting BioMarin Pharmaceutical Inc. (BMRN) earnings to come in at ($0.01) per share for last quarter, but BMRN beat expectations with actual earnings of $0.06---7 cents above the consensus estimate. BMRN also issued earnings guidance for next quarter that is in line with current analyst expectations.
Today's announcement shows that BMRN has not made much progress since last year. This quarter's gain of 0.06 per share, compared with a gain of 0.06 per share during the same quarter a year ago is a negative sign for the company.
We'll have to see if this positive announcement helps BMRN's stock price in the near term. BMRN has gained 0.1 percent during the past month and is currently above its 200-day moving average.
BMRN is a part of the Biotechnology industry---along with stocks like Amgen Inc. (AMGN) andShangPharma Corporation America (SHP)During the next five years, analysts expect the earnings-per-share (EPS) growth rate in the industry to be 15.29 percent. If you compare BMRN's projected EPS growth rate of 31 percent to that of the industry, you can see that analysts expect BMRN to outperform the industry in the future by 16.06 percent.
Analysts also believe AMGN's earnings are going to grow at a rate of 8.64 percent, but we don't have a five-year EPS growth projection for SHP. AMGN has gained 0.04 percent during the past month and is currently above its 200-day moving average. SHP has lost 0 percent during the past month and is currently below its 200-day moving average.
Today's announcement shows that BMRN has not made much progress since last year. This quarter's gain of 0.06 per share, compared with a gain of 0.06 per share during the same quarter a year ago is a negative sign for the company.
We'll have to see if this positive announcement helps BMRN's stock price in the near term. BMRN has gained 0.1 percent during the past month and is currently above its 200-day moving average.
BMRN is a part of the Biotechnology industry---along with stocks like Amgen Inc. (AMGN) andShangPharma Corporation America (SHP)During the next five years, analysts expect the earnings-per-share (EPS) growth rate in the industry to be 15.29 percent. If you compare BMRN's projected EPS growth rate of 31 percent to that of the industry, you can see that analysts expect BMRN to outperform the industry in the future by 16.06 percent.
Analysts also believe AMGN's earnings are going to grow at a rate of 8.64 percent, but we don't have a five-year EPS growth projection for SHP. AMGN has gained 0.04 percent during the past month and is currently above its 200-day moving average. SHP has lost 0 percent during the past month and is currently below its 200-day moving average.
No comments:
Post a Comment